Skip to main content
. Author manuscript; available in PMC: 2016 Aug 10.
Published in final edited form as: Pharmacogenomics J. 2015 Oct 27;16(4):326–335. doi: 10.1038/tpj.2015.65

Table 1.

Study Subjects

COPD Gene NHW COPD Gene AA ECLIPSE GenKOLS NETT
N 2792 811 1757 853 364
Population origin US US Europe/US/New Zealand Norway US
Age 64.7 (8.2) 59.0 (8.2) 63.7 (7.1) 65.6 (10.0) 67.5 (5.8)
Males (%) 55.6 54.7 66.9 60.0 64.8
Pack-years 56.2 (27.8) 42.4 (23.1) 50.3 (27.4) 32.1 (18.5) 66.1 (30.9)
Current smoker (%) 34.7 60.8 35.4 46.9 0
BMI (kg/m2) 28.1 (6.1) 28.0 (6.8) 26.7 (5.6) 25.3 (4.9) 25.0 (3.5)
FEV1 pp (%) 49.7 (18.0) 52.3 (17.7) 47.6 (15.6) 50.7 (17.3) 28.0 (7.4)
FEV1/FVC 0.49 (0.13) 0.53 (0.12) 0.45 (0.12) 0.51 (0.13) 0.32 (0.06)
BDRABS (L) 0.10 (0.15) 0.07 (0.18) 0.12 (0.14) 0.10 (0.14) 0.09 (0.08)
BDRBASE (%) 9.2 (12.4) 7.6 (14.2) 10.7 (13.4) 8.1 (11.7) 13.4 (12.0)
BDRPRED (%) 3.6 (4.9) 2.89 (6.5) 3.9 (4.8) 3.4 (4.7) 3.3 (3.0)

Data are presented as mean (sd) or N (%). NHW: non-Hispanic white; AA: African American; FEV1pp: FEV1 percent predicted; BMI: Body mass index. BDRABS: (Post-BD FEV1 – Pre-BD FEV1); BDRBASE: (BDRABS/(Pre-BD FEV1*100)); BDRPRED: (BDRABS/(FEV1pp*100)).